Eye & ENT Hospital of Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Application of Photosensitive Hydrogel in Intranasal Endoscopic Dacryocystorhinostomy

Not Applicable

Recruiting

Conditions: Chronic Dacryocystitis

Interventions: Device: 6-0 absorbable stitches
Device: Photosensitive hydrogel

First Posted Date: 2024-08-13

Last Posted Date: 2024-08-13

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 20

Registration Number: NCT06551766

Locations: 🇨🇳
Eye & ENT Hospital of Fudan University, Shanghai, China

AR Training Versus Patching in Unilateral Amblyopia

Not Applicable

Not yet recruiting

Conditions: Amblyopia Unilateral

Interventions: Other: AR training
Other: Patching

First Posted Date: 2024-07-12

Last Posted Date: 2024-07-15

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 114

Registration Number: NCT06498206

Locations: 🇨🇳
Eye & ENT Hospital of Fudan University, Shanghai, China

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

Early Phase 1

Recruiting

Conditions: Bacterial Keratitis
Antibiotic-resistant Bacteria
Infections, Bacterial
Corneal Diseases
Eye Diseases
Vision Disorders
Sensation Disorders
Blindness
Antisense Peptide Nucleic Acid
Antibacterial Therapy

Interventions: Drug: ASO

First Posted Date: 2024-06-11

Last Posted Date: 2024-06-11

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 20

Registration Number: NCT06451172

Locations: 🇨🇳
Eye & ENT Hospital of Fudan University, Shanghai, Shanghai, China

Targeting NUDT21 SiRNA Drugs for Patients with Refractory Retinoblastoma

Early Phase 1

Not yet recruiting

Conditions: Retinoblastoma
Refractory

Interventions: Drug: Targeting NUDT21 siRNA drugs

First Posted Date: 2024-05-22

Last Posted Date: 2024-10-29

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 20

Registration Number: NCT06424301

A Comparative Analysis of Speech Perception Between Cochlear Implant Patients and DFNB9 Patients Receiving Gene Therapy

Recruiting

Conditions: Hearing Loss
Genetic Disease
Speech Perception

First Posted Date: 2024-02-01

Last Posted Date: 2024-05-09

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 57

Registration Number: NCT06237790

Locations: 🇨🇳
Eye & ENT Hospital of Fudan University, Shanghai, Shanghai, China

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Phase 3

Recruiting

Conditions: Recurrent Nasopharyngeal Carcinoma

Interventions: Procedure: endoscopic surgery
Drug: Adjuvant therapy in control group,Toripalimab Injection and Gemcitabine based therapy
Drug: Neoadjuvant therapy,Toripalimab Injection and Gemcitabine based therapy
Drug: Adjuvant therapy in experimental group,Toripalimab Injection and Gemcitabine based therapy

First Posted Date: 2024-01-31

Last Posted Date: 2024-06-17

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 154

Registration Number: NCT06235203

Locations: 🇨🇳
Shanghai Sixth People's Hospital, Shanghai, China
🇨🇳
Shanghai Zhongshan Hospital, Shanghai, China
🇨🇳
Eye& ENT Hospital, Fudan University, Shanghai, Shanghai, China

and more 4 locations

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

Phase 3

Recruiting

Conditions: Recurrent Nasopharyngeal Carcinoma

Interventions: Drug: Immunotherapy,Toripalimab Injection
Drug: Chemotherapy,Gemcitabine based regimen

First Posted Date: 2024-01-29

Last Posted Date: 2024-08-13

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 176

Registration Number: NCT06228079

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, China
🇨🇳
Changhai Hospital, Shanghai, China
🇨🇳
Eye& ENT Hospital, Fudan University, Shanghai, Shanghai, China

and more 4 locations

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma

Phase 2

Recruiting

Conditions: Locally Advanced Hypopharyngeal Carcinoma

Interventions: Drug: three cycles (toripalimab + cetuximab + platinum)
Procedure: Radical surgery
Radiation: Radiotherapy or chemoradiotherapy

First Posted Date: 2023-11-30

Last Posted Date: 2024-04-30

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 32

Registration Number: NCT06151743

Locations: 🇨🇳
Eye & ENT Hospital of Fudan University, Shanghai, Shanghai, China

Vestibular Rehabilitation for Unsteadiness After Intratympanic Gentamicin in Patients With Meniere's Disease

Not Applicable

Not yet recruiting

Conditions: Vestibular Disorder

Interventions: Drug: Usual care
Behavioral: vestibular rehabilitation
Other: Health Education

First Posted Date: 2023-11-22

Last Posted Date: 2023-11-22

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 48

Registration Number: NCT06143462

Locations: 🇨🇳
Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, Shanghai, China

Different Dosing Regimens of STOP-AST

Not Applicable

Not yet recruiting

Conditions: Tinnitus
Hearing Loss
Sensorineural Hearing Loss

Interventions: Drug: Prednisone tablet
Drug: Ginkgo Biloba Extract

First Posted Date: 2023-11-09

Last Posted Date: 2023-11-13

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 162

Registration Number: NCT06124703

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy